Results 11 to 20 of about 2,994 (188)
Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances [PDF]
Frontiers in Medicine, 2021 Robert W. Maitta +3 more
doaj +2 more sources
Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study [PDF]
Frontiers in Medicine, 2021 Benoit Brilland +2 more
exaly +2 more sources
Haematologica, 2022 Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by a severe ADAMTS13 deficiency due to the presence of anti-ADAMTS13 auto-antibodies, with subsequent accumulation of circulating ultra-large von Willebrand factor (VWF ...
Edwige Tellier +14 more
doaj +1 more source
Thrombotic microangiopathy in children [PDF]
Pediatric Nephrology, 2022 The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement. It comprises a spectrum of underlying etiologies that may differ in children and adults.
Lilian Monteiro P. Palma +4 more
openaire +3 more sources
Thrombotic Microangiopathies [PDF]
ISRN Hematology, 2012 Thrombotic microangiopathy results from thrombotic occlusion of the microvasculature leading to fragmentation of red blood cells, profound thrombocytopenia, and a microangiopathic hemolytic anemia with elevation of lactate dehydrogenase and negative direct Coomb’s test.
Radhi, Mohamed, Carpenter, Shannon L.
openaire +2 more sources
Thrombosis Update, 2021 Thrombotic microangiopathies are a group of clinical syndromes characterized by microangiopathic hemolytic anemia, thrombocytopenia and end-organ damage, which can compromise the central nervous system.
Xavier Merchán-del-Hierro +5 more
doaj +1 more source
Вестник анестезиологии и реаниматологии, 2021 Thrombotic thrombocytopenic purpura is a disease from the group of thrombotic microangiopathies, the early diagnosis of which is a real challenge in clinical practice.
А. R. Аvidzba +2 more
doaj +1 more source
Thrombotic microangiopathies postrenal transplantation
Indian Journal of Transplantation, 2020 Aims: The aim of the study was to describe 12 cases of thrombotic microangiopathy (TMA) postrenal transplantation and study the causes, treatment, and outcomes.
Kartik Ganesh +5 more
doaj +1 more source
COVID-19 and Thrombotic Thrombocytopenic Purpura: A Case Report
International Journal of Hematology-Oncology and Stem Cell Research, 2021 Endothelial injury by toxins, drugs, immune complexes leads to activation of coagulation cascade and thrombosis, which result in platelet consumption and red blood cell injury. These thrombotic microangiopathies can potentially injure numerous organs and
Maryam Darnahal +3 more
doaj +1 more source
The thrombotic microangiopathies [PDF]
Pediatric Nephrology, 2008 The term thrombotic microangiopathy (TMA) encompasses a group of conditions that are defined by, or result from, a similar histopathological lesion. Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA.
Copelovitch, Lawrence +1 more
openaire +2 more sources